Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Senseonics Holdings (SENS)

Senseonics Holdings (SENS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 355,686
  • Shares Outstanding, K 176,958
  • Annual Sales, $ 18,910 K
  • Annual Income, $ -93,970 K
  • 60-Month Beta 1.32
  • Price/Sales 19.09
  • Price/Cash Flow N/A
  • Price/Book 8.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.16
  • Number of Estimates 4
  • High Estimate -0.14
  • Low Estimate -0.17
  • Prior Year -0.16
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.74 +15.52%
on 06/06/19
2.24 -10.27%
on 06/12/19
-0.08 (-3.83%)
since 05/21/19
3-Month
1.74 +15.52%
on 06/06/19
2.67 -24.72%
on 03/22/19
-0.63 (-23.86%)
since 03/21/19
52-Week
1.74 +15.52%
on 06/06/19
5.29 -62.00%
on 06/22/18
-2.97 (-59.64%)
since 06/21/18

Most Recent Stories

More News
Senseonics to Present Real-World, Long-Term Safety Data of the First Implantable CGM Sensor at the American Diabetes Association's 79th Scientific Sessions

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.01 (-1.47%)
Senseonics to Participate in the Raymond James Life Sciences and MedTech Conference

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.01 (-1.47%)
Senseonics Holdings (SENS) Reports Q1 Loss, Lags Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of -41.67% and -15.38%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

SENS : 2.01 (-1.47%)
Senseonics Holdings, Inc. Reports First Quarter 2019 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the design, development and commercialization of a long-term, implantable continuous glucose monitoring...

SENS : 2.01 (-1.47%)
Senseonics Holdings, Inc. Schedules First Quarter 2019 Earnings Release and Conference Call for May 9, 2019 at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.01 (-1.47%)
Report: Exploring Fundamental Drivers Behind Visteon, Senseonics, Concert Pharmaceuticals, Cincinnati Bell, Protagonist Therapeutics, and THL Credit -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Visteon Corporation (NASDAQ:VC),...

PTGX : 12.02 (+4.16%)
SENS : 2.01 (-1.47%)
CNCE : 10.91 (-1.27%)
CBB : 5.17 (-3.18%)
TCRD : 6.75 (+5.30%)
VC : 54.16 (+1.04%)
Senseonics Unveils Eversense Bridge Program in the U.S.

The Eversense Bridge program aligns with Senseonics' (SENS) strategy of offering innovative yet affordable and hassle-free medical care to diabetic patients.

SENS : 2.01 (-1.47%)
VAR : 137.22 (+0.63%)
PEN : 164.82 (-0.24%)
MASI : 144.37 (-1.81%)
Senseonics Launches the Eversense(R) Bridge Patient Access Program in the U.S.

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM)...

SENS : 2.01 (-1.47%)
Is the Options Market Predicting a Spike in Senseonics Holdings (SENS) Stock?

Investors need to pay close attention to Senseonics Holdings (SENS) stock based on the movements in the options market lately.

SENS : 2.01 (-1.47%)
Senseonics Holdings (SENS) Reports Q4 Loss, Lags Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 73.33% and -8.75%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

SENS : 2.01 (-1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade SENS with:

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

2nd Resistance Point 2.11
1st Resistance Point 2.06
Last Price 2.01
1st Support Level 1.98
2nd Support Level 1.95

See More

52-Week High 5.29
Fibonacci 61.8% 3.93
Fibonacci 50% 3.51
Fibonacci 38.2% 3.10
Last Price 2.01
52-Week Low 1.74

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar